https://www.fiercepharma.com/pharma/pfizers-abrysvo-becomes-first-maternal-rsv-shot-protect-newborns
Already with an approval in hand for older adults, Pfizer’s Abrysvo has become the first vaccine for pregnant women to protect their newborns against respiratory syncytial virus (RSV). | Already with an approval in hand for older adults, Pfizer’s Abrysvo has …
Create an account or login to join the discussion